The present invention relates to an endoprosthesis having elevated scaffolding properties and also elevated flexibility. More particularly, the present invention relates to an endoprosthesis having a plurality of web rings coupled by connectors that are composed of three or more struts of essentially equal length, which extend circumferentially in essentially parallel directions.
Applications of endoprotheses to the superior femoral artery (SFA) and to the popliteal artery (PA) has received increased attention because of the prevalence of peripheral arterial disease (PAD) among older patients and because no known endoprosthesis can adequately supports the SFA and the PA without distorting its architecture during patient motion.
PAD is estimated to affect between 3% and 10% of individuals till the age of 70 and may approach 20% of individuals older than 70 years of age. PAD has been associated with an increased risk of coronary artery disease, cerebrovascular disease, and premature death. Moreover, as a consequence of limited exercise performance and walking ability, individuals who have symptoms of intermittent claudication experience a significantly negative impact on quality of life.
Exercise programs have been recommended as the first line of therapy for PAD. Pharmacotherapy with cilostazol provides additional symptom relief, but patients who fail medical therapy and continue to have resting leg pain or non-healing ulcers eventually become candidates for invasive treatment strategy. Unfortunately, surgical revascularization has associated with higher periprocedural morbidity and mortality, making the surgical option less desirable in elderly patients—a significant proportion of patients with PAD.
Because greater than 50% of individuals with lower extremity claudication have atherosclerotic disease confined to the superficial femoral artery (SFA), endovascular techniques have recently emerged to treat this arterial segment.
Stents, grafts and a variety of other endoprostheses are well known and used in endovascular procedures, such as for treating aneurysms, lining or repairing vessel walls, filtering or controlling fluid flow, and expanding or scaffolding occluded or collapsed vessels. Such endoprostheses can be delivered and used in virtually any accessible body lumen of a human or animal and can be deployed by any of a variety of recognized means.
An endoprosthesis is typically delivered by a catheter system to a desired location or deployment site inside a body lumen of a vessel or other tubular organ. To facilitate such delivery, the endoprosthesis must be capable of having a particularly small cross profile and a sufficient degree of longitudinal flexibility during delivery to allow advancement through the anatomy to the deployed site.
Once deployed, the endoprosthesis should be capable of satisfying a variety of performance characteristics. The endoprosthesis should have sufficient rigidity or outer bias to perform its intended function, such as opening a lumen or supporting a vessel wall. Similarly, the endoprosthesis should retain sufficient flexibility along its length in its expanded condition so that it will not kink, straighten or fracture during or after deployment in a curved vessel. The endoprosthesis should also provide a substantially uniform or otherwise controlled scaffolding of the vessel wall and prevent plaque from protruding into the artery.
One type of endoprosthesis is the stent, which is used for the treatment of atherosclerotic stenosis in blood vessels. After a patient undergoes a percutaneous transluminal angioplasty or similar interventional procedure, a stent may be deployed at the treatment site to maintain patency of the vessel. The stent is configured to scaffold or support the treated blood vessel and may be loaded with a beneficial agent, acting as a delivery platform to reduce restenosis or the like.
Numerous endoprosthesis designs and constructions have been developed to address one or more of the performance characteristics summarized above. For example, a variety of stent designs are disclosed in the following patents: U.S. Pat. No. 4,580,568 to Gianturco; U.S. Pat. No. 5,102,417 to Palmaz; U.S. Pat. No. 5,104,404 to Wolff; U.S. Pat. No. 5,133,732 to Wiktor; U.S. Pat. No. 5,292,331 to Boneau; U.S. Pat. No. 5,514,154 to Lau et al.; U.S. Pat. No. 5,569,295 to Lam; U.S. Pat. No. 5,707,386 to Schnepp-Pesch et al.; U.S. Pat. No. 5,733,303 to Israel et al.; U.S. Pat. No. 5,755,771 to Penn et al.; U.S. Pat. No. 5,776,161 to Globerman; U.S. Pat. No. 5,895,406 to Gray et al.; U.S. Pat. No. 6,033,434 to Borghi; U.S. Pat. No. 6,099,561 to Alt; U.S. Pat. No. 6,106,548 to Roubin et al.; U.S. Pat. No. 6,113,627 to Jang; U.S. Pat. No. 6,132,460 to Thompson; U.S. Pat. No. 6,331,189 to Wolinsky; and U.S. Pat. No. 7,128,756 to Lowe et al., the entireties of which are incorporated herein by reference.
During the treatment of some types of SFA and PA disease, relatively long stent lengths are frequently required, at times causing the treating physician to overlap multiple stents. Further complicating the treatment of SFA and PA disease is the possibility of stent fractures and subsequent restenosis. A particular area of vulnerability is the area through the adductor canal as the SFA continues behind the knee; in fact, the area at the adductor canal is a frequent location for SFA disease likely secondary to the bending, compression, elongation and torsion forces on the artery itself due to the muscular structure surrounding this canal, leading to a lengthening and shortening of up to 15% of the stent between straight and bent positions of a limb. After the stent has been implanted, the body vessel is subjected to repeated traumas caused by the negative interaction of a relatively rigid stent and a softer artery.
In the earlier days of endovascular therapy, it was believed that the area to avoid stenting due to the risk of stent crush or stent fracture was near the bony articulation between the femur and the tibia. It is now believed that the area of critical importance is really superior to this point leading up to the adductor canal, which is a frequent location of SFA lesions. If it is necessary to stent this region, the ability of the stent to withstand the forces present in the SFA is of critical importance. Another risk is the incidence of restenosis, against which self-expanding Nitinol stents have shown better one-year patency rates than other types of stents.
Therefore, it would be desirable for the endoprosthesis to provide an elevated degree of scaffolding to a vessel wall while retaining an elevated degree of flexibility within the operating environments of the SFA and PA.
The present invention relates to an endoprosthesis for delivery within a body lumen that provides an elevated degree of scaffolding and that has an elevated degree of flexibility, making it particularly suited for implantation in body vessels in which extensive bending, compression, elongation, and torsion forces are applied to the endoprosthesis. In different embodiments, the endoprosthesis may be configured as a stent, graft, valve, occlusive device, trocar or aneurysm treatment device for a variety of intralumenal applications, including vascular, coronary, biliary, esophageal, renal, urological and gastrointestinal, for example, for the treatment of SFA and PA diseases.
An endoprosthesis constructed according to the principles of the present invention includes a web structure that is expandable from a contracted configuration to an expanded configuration and that includes a plurality of longitudinally adjacent web rings. Each of the web rings is defined by web elements disposed circumferentially around a longitudinal axis, which are adjoined one to the other at junction bends. A first junction bend in a first web ring is coupled to a second junction bend in a second web ring by a connector that includes three or more struts (for example, five struts) of essentially equal length that extend circumferentially in essentially parallel directions. The struts of the connector are adjoined in sequence by coupling segments that, in one embodiment of the invention, are arcuate in shape.
The connector of the present invention may also include two struts of reduced length, one coupled to the first junction bend and the other one coupled to the second junction bend. To increase density of the endoprosthesis, the coupling segments of one connector may be nested among the coupling segments of another connector adjacent in a circumferential direction.
In different embodiments, the connector may couple a midpoint in the first junction bend to a midpoint in the second junction bend, or may couple an endpoint in the first junction bend to an endpoint in the second junction bend. The first junction bend may be laterally offset in relation to the second junction bend, providing the endoprosthesis with greater ability to absorb torsional stresses.
The connector may span circumferentially for a distance substantially equal to the circumferential spacing between the midpoints of four junction bends, and the interstices between the struts may be narrower than the widths of the struts.
In different embodiments, the endoprosthesis may be a stent, and the struts of the connector may be substantially rectilinear in shape. The web elements may also be substantially rectilinear in shape, or may be shaped like crowns that include a central member disposed essentially parallel to the longitudinal axis of the endoprosthesis in the contracted configuration and connected at its ends to end members that extend at obtuse angles from the central member. In the contracted delivery configuration of the endoprosthesis, the web elements of each web ring are nested one into the other and may be oriented at approximately 180 degrees in relation to the web elements in a neighboring web ring.
The web structure may be manufactured from a shape-memory material and may be configured to self-expand from the contracted configuration to the expanded configuration, or may be expanded by application of a radial pressure to an interior surface of the essentially tubular body, for example, by inflating a balloon disposed inside the endoprosthesis.
The drawings constitute a part of this specification and include exemplary embodiments of the invention, which may be embodied in various forms. It is to be understood that in some instances various aspects of the invention may be shown exaggerated or enlarged to facilitate an understanding of the invention.
Detailed descriptions of embodiments of the invention are provided herein. It is to be understood, however, that the present invention may be embodied in various forms. Therefore, the specific details disclosed herein are not to be interpreted as limiting, but rather as a representative basis for teaching one skilled in the art how to use the present invention in virtually any detailed system, structure or manner.
The present invention relates to an endoprosthesis for delivery within a body lumen that provides an elevated degree of scaffolding and that has an elevated degree of flexibility, making it particularly suited for implantation in body vessels in which extensive bending, compression, elongation, and torsion forces are applied to the endoprosthesis. In different embodiments, the endoprosthesis may be configured as a stent, graft, valve, occlusive device, trocar or aneurysm treatment device for a variety of intralumenal applications, including vascular, coronary, biliary, esophageal, renal, urological and gastrointestinal, for example, for the treatment of SFA and PA diseases.
An endoprosthesis constructed according to the principles of the present invention includes a web structure that is expandable from a contracted delivery configuration to an expanded deployed configuration and that is formed by a plurality of longitudinally adjacent web rings, coupled by connectors that include three or more struts of essentially equal length. The connector struts are joined in sequence and extend circumferentially in essentially parallel directions. For ease of description and without restrictive intent, an embodiment of the invention will be described hereinafter with reference to a stent.
Referring first to
Stent 10 may be produced from a variety of biocompatible materials and may be deployed at a target vessel using techniques also known in the art. For example, stent 10 may be manufactured from a shape memory material such as Nitinol (a nickel-titanium alloy) when stent 10 is structured to self-expand after delivery into the target vessel, or may be manufactured from a plastic or metal material such as stainless steel or cobalt chromium alloys when stent 10 is structured to be expanded by inflating a catheter-mounted balloon on which stent 10 is crimped.
Referring now to
Coupling segments 18 are shown in
Connector 14 also includes two struts 20 and 22 of reduced length, which are disposed at opposite ends of connector 14 and which couple connector 14 to neighboring web rings 26 and 30. More particularly, strut 20 joins connector 14 to a first junction bend 24 in first web ring 26 and strut 22 joins connector 14 to a second junction bend 28 in second web ring 30.
First junction bend 24 and second junction bend 28 are shown in
While
In different embodiments, struts 16 may have different lengths. For example, in the embodiment illustrated in
In different embodiments, struts 16 may also have a variety of different widths. For example, in the embodiment illustrated in
A plurality of connectors are aligned circumferentially to couple first web ring 26 to second web ring 30 and the distances between two circumferentially adjacent connectors may vary in different embodiments of the invention. In the embodiment illustrated in
The web elements of stent 10 may be shaped as crowns 38 adjoined sequentially by junction bends, as illustrated in
In the contracted delivery configuration, crown 38 are nested one into the other. Further, the crowns of neighboring web rings may be disposed in opposite directions, for example, as shown in
A person skilled in the art will appreciate that web elements of still different shapes may be employed in constructing the web rings and that such alternative designs all fall within the spirit and scope of the present invention. For example, the web elements of web rings 26 and 30 may be shaped like essentially rectilinear struts joined one to the other by arcuate junction bends.
The architecture of stent 10 is particularly stable, as can be seen from the photographs enclosed herein as
Therefore, an endoprosthesis constructed according to the principles of the present invention will have a stable architecture, preventing traumas to the vessel and to the stent and reducing fractures of the endoprosthesis during service.
While the invention has been described in connection with the above described embodiments, it is not intended to limit the scope of the invention to the particular forms set forth, but on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the scope of the invention. Further, the scope of the present invention fully encompasses other embodiments that may become obvious to those skilled in the art and the scope of the present invention is limited only by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4475972 | Wong | Oct 1984 | A |
4580568 | Gianturco | Apr 1986 | A |
4738740 | Pinchuk et al. | Apr 1988 | A |
4743252 | Martin, Jr. et al. | May 1988 | A |
4759757 | Pinchuk | Jul 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4800882 | Gianturco | Jan 1989 | A |
4907336 | Gianturco | Mar 1990 | A |
5015253 | MacGregor | May 1991 | A |
5019090 | Pinchuk | May 1991 | A |
5041126 | Gianturco | Aug 1991 | A |
5059211 | Stack et al. | Oct 1991 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5116360 | Pinchuk et al. | May 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5147370 | McNamara et al. | Sep 1992 | A |
5163951 | Pinchuk et al. | Nov 1992 | A |
5171262 | MacGregor | Dec 1992 | A |
5221261 | Termin et al. | Jun 1993 | A |
5282823 | Schwartz et al. | Feb 1994 | A |
5292331 | Boneau | Mar 1994 | A |
5314444 | Gianturco | May 1994 | A |
5370683 | Fontaine | Dec 1994 | A |
5378239 | Termin et al. | Jan 1995 | A |
5380299 | Fearnot et al. | Jan 1995 | A |
5421955 | Lau et al. | Jun 1995 | A |
5443458 | Eury | Aug 1995 | A |
5443496 | Schwartz et al. | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5449382 | Dayton | Sep 1995 | A |
5476508 | Amstrup | Dec 1995 | A |
5496277 | Termin et al. | Mar 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5556414 | Turi | Sep 1996 | A |
5569295 | Lam | Oct 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5591224 | Schwartz et al. | Jan 1997 | A |
5593417 | Rhodes | Jan 1997 | A |
5593442 | Klein | Jan 1997 | A |
5603721 | Lau et al. | Feb 1997 | A |
5609606 | O'Boyle | Mar 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5649952 | Lam | Jul 1997 | A |
5651174 | Schwartz et al. | Jul 1997 | A |
5653747 | Dereume | Aug 1997 | A |
5670161 | Healy et al. | Sep 1997 | A |
5674242 | Phan et al. | Oct 1997 | A |
5674277 | Freitag | Oct 1997 | A |
5693085 | Buirge et al. | Dec 1997 | A |
5695516 | Fischell et al. | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5700285 | Myers et al. | Dec 1997 | A |
5707386 | Schnepp-Pesch et al. | Jan 1998 | A |
5707388 | Lauterjung | Jan 1998 | A |
5709703 | Lukic et al. | Jan 1998 | A |
5709713 | Evans et al. | Jan 1998 | A |
5716393 | Lindenberg et al. | Feb 1998 | A |
5723003 | Winston et al. | Mar 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5728158 | Lau et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5735892 | Myers et al. | Apr 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5735897 | Buirge | Apr 1998 | A |
5738817 | Danforth et al. | Apr 1998 | A |
5741325 | Chaikof et al. | Apr 1998 | A |
5741327 | Frantzen | Apr 1998 | A |
5743874 | Fischell et al. | Apr 1998 | A |
5749880 | Banas et al. | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755772 | Evans et al. | May 1998 | A |
5755774 | Pinchuk | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776181 | Lee et al. | Jul 1998 | A |
5776183 | Kanesaka et al. | Jul 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5800526 | Anderson et al. | Sep 1998 | A |
5807404 | Richter | Sep 1998 | A |
5810868 | Lashinski et al. | Sep 1998 | A |
5810870 | Myers et al. | Sep 1998 | A |
5810872 | Kanesaka et al. | Sep 1998 | A |
5814063 | Freitag | Sep 1998 | A |
5817126 | Imran | Oct 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824045 | Alt | Oct 1998 | A |
5824048 | Tuch | Oct 1998 | A |
5824054 | Khosravi et al. | Oct 1998 | A |
5824059 | Wijay | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5836964 | Richter et al. | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5846247 | Unsworth et al. | Dec 1998 | A |
5853419 | Imran | Dec 1998 | A |
5855598 | Pinchuk | Jan 1999 | A |
5855600 | Alt | Jan 1999 | A |
5860999 | Schnepp-Pesch et al. | Jan 1999 | A |
5861027 | Trapp | Jan 1999 | A |
5868781 | Killion | Feb 1999 | A |
5871538 | Dereume | Feb 1999 | A |
5876449 | Starck et al. | Mar 1999 | A |
5876450 | Johlin, Jr. | Mar 1999 | A |
5895406 | Gray et al. | Apr 1999 | A |
5897589 | Cottenceau et al. | Apr 1999 | A |
5922021 | Jang | Jul 1999 | A |
5928248 | Acker | Jul 1999 | A |
5938682 | Hojeibane et al. | Aug 1999 | A |
5948018 | Dereume et al. | Sep 1999 | A |
5954743 | Jang | Sep 1999 | A |
5968091 | Pinchuk et al. | Oct 1999 | A |
5968561 | Batchelder et al. | Oct 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
5984965 | Knapp et al. | Nov 1999 | A |
6019789 | Dinh et al. | Feb 2000 | A |
6027526 | Limon et al. | Feb 2000 | A |
6033433 | Ehr et al. | Mar 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6039756 | Jang | Mar 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6056767 | Boussignac et al. | May 2000 | A |
6059811 | Pinchasik et al. | May 2000 | A |
6068656 | Von Oepen | May 2000 | A |
6071308 | Ballou et al. | Jun 2000 | A |
6086610 | Duerig et al. | Jul 2000 | A |
6099561 | Alt | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6113627 | Jang | Sep 2000 | A |
6117165 | Becker | Sep 2000 | A |
6117535 | Szycher et al. | Sep 2000 | A |
6132460 | Thompson | Oct 2000 | A |
6136023 | Boyle | Oct 2000 | A |
6152957 | Jang | Nov 2000 | A |
6165212 | Dereume et al. | Dec 2000 | A |
6168409 | Fare | Jan 2001 | B1 |
6174326 | Kitaoka et al. | Jan 2001 | B1 |
6179868 | Burpee et al. | Jan 2001 | B1 |
6190403 | Fischell et al. | Feb 2001 | B1 |
6193744 | Ehr et al. | Feb 2001 | B1 |
6193747 | Von Oepen | Feb 2001 | B1 |
6200334 | Jang | Mar 2001 | B1 |
6200335 | Igaki | Mar 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6231600 | Zhong | May 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6245101 | Drasler et al. | Jun 2001 | B1 |
6253443 | Johnson | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6261318 | Lee et al. | Jul 2001 | B1 |
6264688 | Herklotz et al. | Jul 2001 | B1 |
6264690 | Von Oepen | Jul 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6299604 | Ragheb et al. | Oct 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6325825 | Kula et al. | Dec 2001 | B1 |
6331189 | Wolinsky et al. | Dec 2001 | B1 |
6332089 | Acker et al. | Dec 2001 | B1 |
6340366 | Wijay | Jan 2002 | B2 |
6348065 | Brown et al. | Feb 2002 | B1 |
6377835 | Schoenberg et al. | Apr 2002 | B1 |
6395020 | Ley et al. | May 2002 | B1 |
6416539 | Hassdenteufel | Jul 2002 | B1 |
6436132 | Patel et al. | Aug 2002 | B1 |
6443982 | Israel et al. | Sep 2002 | B1 |
6451049 | Vallana et al. | Sep 2002 | B2 |
6485508 | McGuinness | Nov 2002 | B1 |
6488702 | Besselink | Dec 2002 | B1 |
6491718 | Ahmad | Dec 2002 | B1 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6506211 | Skubitz et al. | Jan 2003 | B1 |
6508834 | Pinchasik et al. | Jan 2003 | B1 |
6540776 | Sanders Millare et al. | Apr 2003 | B2 |
6558415 | Thompson | May 2003 | B2 |
6562065 | Shanley | May 2003 | B1 |
6572646 | Boylan et al. | Jun 2003 | B1 |
6589276 | Pinchasik et al. | Jul 2003 | B2 |
6602285 | Von Oepen et al. | Aug 2003 | B1 |
6616689 | Ainsworth et al. | Sep 2003 | B1 |
6624097 | Martin et al. | Sep 2003 | B2 |
D481139 | Seibold et al. | Oct 2003 | S |
6629994 | Gomez et al. | Oct 2003 | B2 |
6652574 | Jayaraman | Nov 2003 | B1 |
6676701 | Rourke et al. | Jan 2004 | B2 |
6679911 | Burgermeister | Jan 2004 | B2 |
6682554 | Oepen et al. | Jan 2004 | B2 |
6723119 | Pinchasik et al. | Apr 2004 | B2 |
6730252 | Teoh et al. | May 2004 | B1 |
6740114 | Burgermeister | May 2004 | B2 |
6749629 | Hong et al. | Jun 2004 | B1 |
6755856 | Fierens et al. | Jun 2004 | B2 |
6761733 | Chobotov et al. | Jul 2004 | B2 |
6770088 | Jang | Aug 2004 | B1 |
6776794 | Hong et al. | Aug 2004 | B1 |
6786922 | Schaeffer | Sep 2004 | B2 |
6790227 | Burgermeister | Sep 2004 | B2 |
6796999 | Pinchasik | Sep 2004 | B2 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6846323 | Yip et al. | Jan 2005 | B2 |
6875228 | Pinchasik et al. | Apr 2005 | B2 |
6881222 | White et al. | Apr 2005 | B2 |
6896697 | Yip et al. | May 2005 | B1 |
6913619 | Brown et al. | Jul 2005 | B2 |
6942689 | Majercak | Sep 2005 | B2 |
6955686 | Majercak et al. | Oct 2005 | B2 |
6998060 | Tomonto | Feb 2006 | B2 |
7029493 | Majercak et al. | Apr 2006 | B2 |
7060093 | Dang et al. | Jun 2006 | B2 |
7128756 | Lowe et al. | Oct 2006 | B2 |
7141062 | Pinchasik et al. | Nov 2006 | B1 |
7179286 | Lenz | Feb 2007 | B2 |
7204848 | Brown et al. | Apr 2007 | B1 |
7329277 | Addonizio et al. | Feb 2008 | B2 |
7520892 | Ainsworth et al. | Apr 2009 | B1 |
7611531 | Calisse | Nov 2009 | B2 |
7625398 | Clifford et al. | Dec 2009 | B2 |
7686843 | Moore | Mar 2010 | B2 |
7766956 | Jang | Aug 2010 | B2 |
20010007955 | Drasler et al. | Jul 2001 | A1 |
20010027339 | Boatman et al. | Oct 2001 | A1 |
20010049549 | Boylan et al. | Dec 2001 | A1 |
20020019660 | Gianotti et al. | Feb 2002 | A1 |
20020055770 | Doran et al. | May 2002 | A1 |
20020065549 | White et al. | May 2002 | A1 |
20020107560 | Richter | Aug 2002 | A1 |
20020111669 | Pazienza et al. | Aug 2002 | A1 |
20020113331 | Zhang et al. | Aug 2002 | A1 |
20020151964 | Smith et al. | Oct 2002 | A1 |
20020169499 | Zilla et al. | Nov 2002 | A1 |
20030055487 | Calisse | Mar 2003 | A1 |
20030083736 | Brown et al. | May 2003 | A1 |
20030114918 | Garrison et al. | Jun 2003 | A1 |
20030120334 | Gerberding | Jun 2003 | A1 |
20040002753 | Burgermeister et al. | Jan 2004 | A1 |
20040051201 | Greenhalgh et al. | Mar 2004 | A1 |
20040093073 | Lowe et al. | May 2004 | A1 |
20040102836 | Fischell et al. | May 2004 | A1 |
20040126405 | Sahatjian et al. | Jul 2004 | A1 |
20040167615 | Lenz | Aug 2004 | A1 |
20040193250 | Von Oepen et al. | Sep 2004 | A1 |
20040230293 | Yip et al. | Nov 2004 | A1 |
20040236407 | Fierens et al. | Nov 2004 | A1 |
20040243220 | Gianotti et al. | Dec 2004 | A1 |
20040267353 | Gregorich | Dec 2004 | A1 |
20050004650 | Oepen et al. | Jan 2005 | A1 |
20050004651 | Von Oepen et al. | Jan 2005 | A1 |
20050004658 | Oepen et al. | Jan 2005 | A1 |
20050004659 | Von Oepen et al. | Jan 2005 | A1 |
20050004662 | Von Oepen et al. | Jan 2005 | A1 |
20050043777 | Von Oepen et al. | Feb 2005 | A1 |
20050043778 | Von Oepen et al. | Feb 2005 | A1 |
20050075716 | Yan | Apr 2005 | A1 |
20050222671 | Schaeffer et al. | Oct 2005 | A1 |
20060015173 | Clifford et al. | Jan 2006 | A1 |
20060106452 | Niermann | May 2006 | A1 |
20060142844 | Lowe et al. | Jun 2006 | A1 |
20060175727 | Fierens et al. | Aug 2006 | A1 |
20060184232 | Gianotti et al. | Aug 2006 | A1 |
20060206195 | Calisse | Sep 2006 | A1 |
20060247759 | Burpee et al. | Nov 2006 | A1 |
20070021827 | Lowe et al. | Jan 2007 | A1 |
20070021834 | Young et al. | Jan 2007 | A1 |
20070135891 | Schneider | Jun 2007 | A1 |
20070179593 | Fierens et al. | Aug 2007 | A1 |
20070179601 | Fierens et al. | Aug 2007 | A1 |
20070213800 | Fierens et al. | Sep 2007 | A1 |
20070299505 | Gregorich et al. | Dec 2007 | A1 |
20080077231 | Heringes et al. | Mar 2008 | A1 |
20080294239 | Casey | Nov 2008 | A1 |
20080294240 | Casey | Nov 2008 | A1 |
20090163992 | Osman et al. | Jun 2009 | A1 |
20090163997 | Casey | Jun 2009 | A1 |
20090163998 | Casey | Jun 2009 | A1 |
20100057190 | Issenmann | Mar 2010 | A1 |
20110004289 | Oepen et al. | Jan 2011 | A1 |
20120165921 | Casey | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
2309079 | Nov 2004 | CA |
19840645 | Sep 1998 | DE |
0357003 | Mar 1990 | EP |
0221570 | Jan 1991 | EP |
565251 | Oct 1993 | EP |
0699451 | Mar 1996 | EP |
0709067 | May 1996 | EP |
0808614 | Nov 1997 | EP |
0815806 | Jan 1998 | EP |
0928605 | Jul 1999 | EP |
0950386 | Oct 1999 | EP |
0983753 | Mar 2000 | EP |
1042997 | Oct 2000 | EP |
1095631 | May 2001 | EP |
1516600 | Mar 2005 | EP |
2774279 | Aug 1999 | FR |
2344053 | May 2000 | GB |
7-24072 | Jan 1995 | JP |
08-206226 | Aug 1996 | JP |
09-010318 | Jan 1997 | JP |
10-328216 | Dec 1998 | JP |
11-299901 | Feb 1999 | JP |
2000312721 | Nov 2000 | JP |
WO9117789 | Nov 1991 | WO |
WO9621404 | Jul 1996 | WO |
WO9625124 | Aug 1996 | WO |
WO9626689 | Sep 1996 | WO |
WO9712563 | Apr 1997 | WO |
WO9712564 | Apr 1997 | WO |
WO9714375 | Apr 1997 | WO |
WO9832412 | Jul 1998 | WO |
WO9847447 | Oct 1998 | WO |
WO9907308 | Feb 1999 | WO |
WO9917680 | Apr 1999 | WO |
WO9923976 | May 1999 | WO |
WO9938456 | Aug 1999 | WO |
WO9938458 | Aug 1999 | WO |
WO9939660 | Aug 1999 | WO |
WO9939663 | Aug 1999 | WO |
WO9949928 | Oct 1999 | WO |
WO 0013611 | Mar 2000 | WO |
WO0018328 | Apr 2000 | WO |
WO0032241 | Jun 2000 | WO |
WO0045744 | Aug 2000 | WO |
WO0053119 | Sep 2000 | WO |
WO0101885 | Jan 2001 | WO |
WO0182835 | Nov 2001 | WO |
WO0226164 | Apr 2002 | WO |
WO02064061 | Aug 2002 | WO |
WO02064065 | Aug 2002 | WO |
WO02094127 | Nov 2002 | WO |
WO03009779 | Feb 2003 | WO |
WO03057076 | Jul 2003 | WO |
WO2004087015 | Oct 2004 | WO |
WO2006055533 | May 2006 | WO |
WO2006066886 | Jun 2006 | WO |
WO2006099449 | Sep 2006 | WO |
WO2008042618 | Apr 2008 | WO |
WO2008142566 | Nov 2008 | WO |
WO2009046973 | Apr 2009 | WO |
WO2009080326 | Jul 2009 | WO |
WO2009080327 | Jul 2009 | WO |
Entry |
---|
U.S. Appl. No. 10/859,636, filed Mar. 30, 2011, Issue Notification. |
U.S. Appl. No. 11/731,820, filed Mar. 30, 2011, Issue Notification. |
U.S. Appl. No. 12/949,481, filed Nov. 18, 2010, Schneider. |
U.S. Appl. No. 12/608,335, filed Oct. 29, 2009, Calisse. |
U.S. Appl. No. 10/241,523, Aug. 18, 2004, Office Action. |
U.S. Appl. No. 10/241,523, Oct. 25, 2004, Office Action. |
U.S. Appl. No. 10/241,523, Mar. 8, 2005, Office Action. |
U.S. Appl. No. 10/241,523, Jun. 3, 2005, Office Action. |
U.S. Appl. No. 10/241,523, Aug. 23, 2005, Office Action. |
U.S. Appl. No. 10/241,523, Nov. 16, 2005, Office Action. |
U.S. Appl. No. 10/241,523, Apr. 27, 2006, Office Action. |
U.S. Appl. No. 10/743,857, Feb. 12, 2010, Notice of Allowance. |
U.S. Appl. No. 10/859,636, Feb. 1, 2010, Notice of Allowance. |
U.S. Appl. No. 10/903,013, Feb. 12, 2010, Notice of Allowance. |
U.S. Appl. No. 10/903,014, Feb. 5, 2010, Notice of Allowance. |
U.S. Appl. No. 10/955,425, Feb. 26, 2010, Notice of Allowance. |
U.S. Appl. No. 11/404,450, Apr. 22, 2010, Office Action. |
U.S. Appl. No. 11/435,260, Jan. 10, 2008, Office Action. |
U.S. Appl. No. 11/435,260, Mar. 26, 2008, Office Action. |
U.S. Appl. No. 11/435,260, Dec. 16, 2008, Office Action. |
U.S. Appl. No. 11/435,260, Jun. 18, 2009, Notice of Allowance. |
U.S. Appl. No. 11/435,260, Jun. 26, 2009, Notice of Allowance. |
U.S. Appl. No. 11/731,820, Jan. 27, 2010, Office Action. |
U.S. Appl. No. 11/731,882, Feb. 3, 2010, Office Action. |
U.S. Appl. No. 11/805,584, Apr. 27, 2009, Office Action. |
U.S. Appl. No. 11/805,584, Oct. 29, 2009, Office Action. |
U.S. Appl. No. 11/805,584, Mar. 15, 2010, Office Action. |
U.S. Appl. No. 11/961,384, May 26, 2009, Office Action. |
U.S. Appl. No. 11/961,384, Oct. 8, 2009, Office Action. |
U.S. Appl. No. 11/961,754, Jul. 22, 2009, Office Action. |
U.S. Appl. No. 11/961,754, Apr. 5, 2010, Notice of Allowance. |
U.S. Appl. No. 11/973,707, Jun. 9, 2009, Office Action. |
U.S. Appl. No. 11/973,707, Mar. 19, 2010, Office Action. |
U.S. Appl. No. 11/961,775, Oct. 1, 2009, Office Action. |
U.S. Appl. No. 11/961,775, Mar. 31, 2010, Office Action. |
U.S. Appl. No. 12/608,335, May 11, 2012, Office Action. |
U.S. Appl. No. 12/966,916, May 23, 2012, Notice of Allowance. |
U.S. Appl. No. 60/637,495, filed Dec. 20, 2004, Fierens et al. |
U.S. Appl. No. 09/582,318, Aug. 14, 2002, Office Action. |
U.S. Appl. No. 09/582,318, Mar. 7, 2003, Notice of Allowance. |
U.S. Appl. No. 09/742,144, Sep. 24, 2002, Office Action. |
U.S. Appl. No. 09/742,144, May 14, 2003, Office Action. |
U.S. Appl. No. 09/742,144, Aug. 29, 2003, Notice of Allowance. |
U.S. Appl. No. 09/916,394, Aug. 12, 2003, Office Action. |
U.S. Appl. No. 09/916,394, Oct. 9, 2003, Office Action. |
U.S. Appl. No. 09/916,394, Mar. 2, 2004, Office Action. |
U.S. Appl. No. 09/967,789, Sep. 17, 2003, Office Action. |
U.S. Appl. No. 09/967,789, Feb. 17, 2004, Notice of Allowance. |
U.S. Appl. No. 10/743,857, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/743,857, Nov. 16, 2007, Office Action. |
U.S. Appl. No. 10/743,857, May 8, 2008, Office Action. |
U.S. Appl. No. 10/743,857, Jan. 6, 2009, Office Action. |
U.S. Appl. No. 10/743,857, May 27, 2009, Office Action. |
U.S. Appl. No. 10/743,857, Jun. 25, 2010, Notice of Allowance. |
U.S. Appl. No. 10/859,636, Jun. 1, 2007, Office Action. |
U.S. Appl. No. 10/859,636, Dec. 31, 2007, Office Action. |
U.S. Appl. No. 10/859,636, Apr. 15, 2008, Office Action. |
U.S. Appl. No. 10/859,636, Oct. 1, 2008, Notice of Allowance. |
U.S. Appl. No. 10/859,636, Mar. 5, 2009, Office Action. |
U.S. Appl. No. 10/859,636, Oct. 19, 2009, Notice of Allowance. |
U.S. Appl. No. 10/859,636, May 19, 2010, Notice of Allowance. |
U.S. Appl. No. 10/884,613, Mar. 30, 2005, Office Action. |
U.S. Appl. No. 10/884,613, Nov. 14, 2005, Office Action. |
U.S. Appl. No. 10/903,013, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/903,013, Nov. 19, 2007, Office Action. |
U.S. Appl. No. 10/903,013, May 14, 2008, Office Action. |
U.S. Appl. No. 10/903,013, Jan. 5, 2009, Office Action. |
U.S. Appl. No. 10/903,013, May 27, 2009, Office Action. |
U.S. Appl. No. 10/903,013, Jun. 24, 2010, Notice of Allowance. |
U.S. Appl. No. 10/903,014, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/903,014, Nov. 16, 2007, Office Action. |
U.S. Appl. No. 10/903,014, May 13, 2008, Office Action. |
U.S. Appl. No. 10/903,014, Jan. 13, 2009, Office Action. |
U.S. Appl. No. 10/903,014, Jun. 1, 2009, Office Action. |
U.S. Appl. No. 10/903,014, May 26, 2010, Office Action. |
U.S. Appl. No. 10/903,014, Jun. 24, 2010, Notice of Allowance. |
U.S. Appl. No. 10/903,080, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/903,080, Nov. 19, 2007, Office Action. |
U.S. Appl. No. 10/903,080, May 12, 2008, Office Action. |
U.S. Appl. No. 10/903,080, Dec. 30, 2008, Office Action. |
U.S. Appl. No. 10/903,080, May 27, 2009, Office Action. |
U.S. Appl. No. 10/903,080, Jan. 13, 2010, Notice of Allowance. |
U.S. Appl. No. 10/909,117, Aug. 22, 2007, Office Action. |
U.S. Appl. No. 10/909,117, May 12, 2008, Office Action. |
U.S. Appl. No. 10/909,117, Dec. 30, 2008, Office Action. |
U.S. Appl. No. 10/909,117, May 27, 2009, Office Action. |
U.S. Appl. No. 10/909,117, Jan. 13, 2010, Notice of Allowance. |
U.S. Appl. No. 10/909,118, Mar. 29, 2007, Office Action. |
U.S. Appl. No. 10/909,118, Nov. 19, 2007, Office Action. |
U.S. Appl. No. 10/909,118, May 12, 2008, Office Action. |
U.S. Appl. No. 10/909,118, Jan. 5, 2009, Office Action. |
U.S. Appl. No. 10/909,118, Jul. 24, 2009, Office Action. |
U.S. Appl. No. 10/909,118, Jan. 13, 2010, Notice of Allowance. |
U.S. Appl. No. 10/954,948, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/954,948, Nov. 16, 2007, Office Action. |
U.S. Appl. No. 10/954,948, May 15, 2008, Office Action. |
U.S. Appl. No. 10/954,948, Jan. 13, 2009, Office Action. |
U.S. Appl. No. 10/954,948, May 29, 2009, Office Action. |
U.S. Appl. No. 10/954,948, Jan. 13, 2010, Notice of Allowance. |
U.S. Appl. No. 10/954,948, Jul. 6, 2010, Notice of Allowance. |
U.S. Appl. No. 10/955,425, Mar. 15, 2007, Office Action. |
U.S. Appl. No. 10/955,425, Nov. 16, 2007, Office Action. |
U.S. Appl. No. 10/955,425, May 13, 2008, Office Action. |
U.S. Appl. No. 10/955,425, Jan. 13, 2009, Office Action. |
U.S. Appl. No. 10/955,425, May 28, 2009, Office Action. |
U.S. Appl. No. 10/955,425, Jun. 25, 2010, Notice of Allowance. |
U.S. Appl. No. 11/313,110, Jan. 8, 2008, Office Action. |
U.S. Appl. No. 11/313,110, Jul. 2, 2008, Office Action. |
U.S. Appl. No. 11/313,110, Mar. 3, 2009, Office Action. |
U.S. Appl. No. 11/313,110, Nov. 2, 2009, Notice of Allowance. |
U.S. Appl. No. 11/313,110, Feb. 18, 2010, Notice of Allowance. |
U.S. Appl. No. 11/313,110, Jun. 15, 2010, Notice of Allowance. |
U.S. Appl. No. 11/404,450, Feb. 4, 2009, Office Action. |
U.S. Appl. No. 11/404,450, Mar. 17, 2009, Office Action. |
U.S. Appl. No. 11/404,450, Sep. 30, 2009, Office Action. |
U.S. Appl. No. 11/601,475, Jul. 22, 2008, Office Action. |
U.S. Appl. No. 11/601,475, Jan. 6, 2009, Office Action. |
U.S. Appl. No. 11/601,475, Jun. 1, 2009, Office Action. |
U.S. Appl. No. 11/601,475, Jan. 15, 2010, Notice of Allowance. |
U.S. Appl. No. 11/601,475, Jul. 9, 2010, Notice of Allowance. |
U.S. Appl. No. 11/732,244, Sep. 28, 2009, Office Action. |
U.S. Appl. No. 11/732,244, May 5, 2010, Notice of Allowance. |
U.S. Appl. No. 11/732,244, Jun. 21, 2010, Notice of Allowance. |
U.S. Appl. No. 11/973,707, Oct. 12, 2011, Notice of Allowance. |
U.S. Appl. No. 10/909,118, Sep. 21, 2010, Notice of Allowance. |
U.S. Appl. No. 11/805,584, Oct. 4, 2010, Office Action. |
U.S. Appl. No. 12/895,032, filed Sep. 30, 2010, Fierens et al. |
U.S. Appl. No. 10/903,080, Jan. 26, 2011, Issue Notification. |
U.S. Appl. No. 11/601,475, Jan. 26, 2011, Issue Notification. |
U.S. Appl. No. 12/966,916, Jun. 10, 2011, Office Action. |
U.S. Appl. No. 12/895,032, Jul. 3, 2012, Office Action. |
U.S. Appl. No. 11/973,707, Feb. 15, 2012, Issue Notification. |
U.S. Appl. No. 12/949,481, Feb. 15, 2012, Office Action. |
U.S. Appl. No. 11/731,882, Dec. 14, 2011, Issue Notification. |
U.S. Appl. No. 12/949,481, Jan. 5, 2012, Office Action. |
U.S. Appl. No. 12/966,916, Jan. 5, 2012, Office Action. |
U.S. Appl. No. 11/404,450, Jan. 31, 2012, Office Action. |
U.S. Appl. No. 12/895,032, Feb. 1, 2012, Office Action. |
U.S. Appl. No. 11/805,584, May 12, 2011, Notice of Allowance. |
U.S. Appl. No. 13/089,039, filed Apr. 8, 2011, Fierens et al. |
U.S. Appl. No. 10/743,857, Aug. 18, 2010, Issue Notification. |
U.S. Appl. No. 10/903,013, Aug. 18, 2010, Issue Notification. |
U.S. Appl. No. 11/731,820, Aug. 5, 2010, Notice of Allowance. |
U.S. Appl. No. 11/961,754, Jul. 28, 2010, Notice of Allowance. |
U.S. Appl. No. 11/404,450, Nov. 26, 2010, Office Action. |
U.S. Appl. No. 10/859,636, Dec. 9, 2010, Notice of Allowance. |
U.S. Appl. No. 11/961,754, Nov. 23, 2010, Issue Notification. |
U.S. Appl. No. 12/966,916, filed Dec. 13, 2010, Casey. |
U.S. Appl. No. 10/909,117, Nov. 17, 2010, Issue Notification. |
U.S. Appl. No. 11/731,820, Dec. 16, 2010, Notice of Allowance. |
U.S. Appl. No. 11/404,450, Aug. 10, 2011, Office Action. |
U.S. Appl. No. 11/961,384, Apr. 23, 2012, Office Action. |
U.S. Appl. No. 12/875,971, Apr. 19, 2012, Office Action. |
U.S. Appl. No. 11/731,882, Aug. 29, 2011, Notice of Allowance. |
U.S. Appl. No. 11/805,584, Aug. 24, 2011, Issue Notification. |
U.S. Appl. No. 10/903,014, Aug. 25, 2010, Issue Notification. |
U.S. Appl. No. 10/903,080, Sep. 16, 2010, Notice of Allowance. |
U.S. Appl. No. 10/909,117, Sep. 16, 2010, Notice of Allowance. |
U.S. Appl. No. 10/955,425, Sep. 30, 2010, Notice of Allowance. |
U.S. Appl. No. 11/313,110, Sep. 29, 2010, Issue Notification. |
U.S. Appl. No. 11/731,882, Sep. 1, 2010, Office Action. |
U.S. Appl. No. 11/732,244, Sep. 22, 2010, Issue Notification. |
Landers, Rüdiger and Mülhaupt, Rolf “Desktop manufacturing of complex objects, prototypes and biomedical scaffolds by means of computer-assisted design combined with computer-guided 3D plotting of polymers and reactive oligomers” Macromolecular Materials and Engineering , vol. 282, Issue 1, pp. 17-21, Oct. 2000. |
U.S. Appl. No. 11/961,384, Aug. 21, 2012, Notice of Allowance. |
U.S. Appl. No. 12/875,971, Jul. 26, 2012, Notice of Allowance. |
U.S. Appl. No. 12/875,971, Oct. 17, 2012, Issue Notification. |
U.S. Appl. No. 12/949,481, Aug. 13, 2012, Notice of Allowance. |
U.S. Appl. No. 13/089,039, Oct. 16, 2012, Office Action. |
U.S. Appl. No. 13/411,135, Oct. 16, 2012, Restriction Requirement. |
U.S. Appl. No. 12/895,032, Aug. 13, 2013, Office Action. |
U.S. Appl. No. 13/089,039, Jun. 28, 2013, Office Action. |
U.S. Appl. No. 13/411,135, Mar. 15, 2013, Office Action. |
U.S. Appl. No. 13/801,469, filed Mar. 13, 2013, Von Oepen et al. |
U.S. Appl. No. 12/608,335, Dec. 2, 2013, Office Action. |
U.S. Appl. No. 12/608,335, Mar. 3, 2014, Advisory Action. |
U.S. Appl. No. 12/895,032, Oct. 29, 2013, Office Action. |
U.S. Appl. No. 12/895,032, Mar. 14, 2014, Office Action. |
U.S. Appl. No. 13/089,039, Sep. 26, 2013, Office Action. |
U.S. Appl. No. 13/089,039, Apr. 14, 2014, Notice of Allowance. |
U.S. Appl. No. 13/089,039, Aug. 6, 2014, Issue Notification. |
U.S. Appl. No. 13/411,135, Oct. 8, 2013, Office Action. |
U.S. Appl. No. 13/411,135, Mar. 14, 2014, Office Action. |
U.S. Appl. No. 14/323,658, filed Jul. 3, 2014, Fierens et al. |
U.S. Appl. No. 13/411,135, Oct. 24, 2014, Office Action. |
Number | Date | Country | |
---|---|---|---|
20090163996 A1 | Jun 2009 | US |